ICAM1 and myocardial infarction: In a prospective cohort study designed to evaluate markers of coronary risk, increased plasma levels of ICAM-1 were associated with the risk of myocardial infarction and angina pectoris, indicating circulating levels of ICAM-1 as possible risk markers for future coronary events [67].